CDC is currently performing a multi-state investigation into clusters of Burkholderia cepacia among patients in intensive care units. CDPHE and other state health departments are assisting CDC in this investigation.
Preliminary information indicates that a contaminated liquid docusate product might be related to cases. CDC is continuing to investigate. The recommendation by CDC to avoid using any liquid docusate products has been expanded to include all patient populations. Providers should not give any patients liquid docusate products.
Facilities that identify B. cepacia complex infections in non-cystic fibrosis patients or clusters of B. cepacia complex infections in non-cystic fibrosis patients should sequester all liquid docusate products.
CDPHE continues to request facilities report the following:
– Any clusters of B. cepacia or other Burkholderia species identified since January 2016;
– Any cases of B. cepacia or other Burkholderia species in non-cystic fibrosis patients identified since January 2016.
Please notify the Communicable Disease Branch at CDPHE by contacting Geoff Brousseau at 303-692-2766 firstname.lastname@example.org.